Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: What are the current options?

Corley, 2001, Oesophageal and gastric cardia adenocarcinomas: Analysis of regional variation using the cancer incidence in five continents database, Int J Epidemiol, 30, 1415, 10.1093/ije/30.6.1415 Blot, 1991, Rising incidence of adenocarcinoma of the esophagus and gastric cardia, JAMA, 265, 1287, 10.1001/jama.1991.03460100089030 Bollschweiler, 2001, Demographic variations in the rising incidence of esophageal adenocarcinoma in white males, Cancer, 92, 549, 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L Mariette, 2003, Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease, Cancer, 97, 1616, 10.1002/cncr.11228 Sasako, 2003, Principles of surgical treatment for curable gastric cancer, J Clin Oncol, 21, 274s, 10.1200/JCO.2003.09.172 Stein, 2000, Limited resection for early adenocarcinoma in Barrett's esophagus, Ann Surg, 232, 733, 10.1097/00000658-200012000-00002 Thésaurus national de cancérologie digestive. Chapitres cancer de l’œsophage et cancer de l’estomac. http://www.snfge.asso.fr/01-Bibliotheque/0GThesaurus-cancerologie/publication5/sommaire-thesaurus.asp Poon, 1998, Esophagectomy for carcinoma of the esophagus in the elderly: Results of current surgical management, Ann Surg, 227, 357, 10.1097/00000658-199803000-00007 Sobin, 2009 van Vliet, 2008, Staging investigations for oesophageal cancer: a meta-analysis, Br J Cancer, 98, 547, 10.1038/sj.bjc.6604200 Lightdale, 2005, Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer, J Clin Oncol, 23, 4483, 10.1200/JCO.2005.20.644 Lordick, 2007, PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial, Lancet Oncol, 8, 797, 10.1016/S1470-2045(07)70244-9 Pech, 2007, Endoscopic resection of early oesophageal cancer, Gut, 56, 1625, 10.1136/gut.2006.112110 DeMeester, 2006, Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment, Ann Surg Oncol, 13, 12, 10.1245/ASO.2005.12.025 Okines, 2009, Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer, Ann Oncol, 1529, 10.1093/annonc/mdp047 Holscher, 2009, Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration, Ann Surg, 250, 791, 10.1097/SLA.0b013e3181bdd3e4 Hermanek, 1995, pTNM and residual tumor classifications: problems of assessment and prognostic significance, World J Surg, 19, 184, 10.1007/BF00308624 Medical research council oesophageal cancer working group, 2002, Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial, Lancet, 359, 1727, 10.1016/S0140-6736(02)08651-8 Kelsen, 2007, Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer, J Clin Oncol, 25, 3719, 10.1200/JCO.2006.10.4760 Siewert, 2000, Adenocarcinoma of the oesophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients, Ann Surg, 232, 353, 10.1097/00000658-200009000-00007 Peracchia, 2000, Outcome of surgical treatment Sauvanet, 2003 Feith, 2006, Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients, Surg Oncol Clin N Am, 15, 751, 10.1016/j.soc.2006.07.015 Lerut, 1998, Esophageal surgery at the end of the millennium, J Thorac Cardiovasc Surg, 116, 1, 10.1016/S0022-5223(98)70237-5 Mariette, 2002, Surgical management of and long-term survival after adenocarcinoma of the cardia, Br J Surg, 89, 1156, 10.1046/j.1365-2168.2002.02185.x Dresner, 2001, The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction, Surgery, 129, 103, 10.1067/msy.2001.110024 Wu, 2003, The role of surgery in the management of oesophageal cancer, Lancet Oncol, 4, 481, 10.1016/S1470-2045(03)01167-7 Slim, 2009, Digestive oncology: surgical practices, J Chir (Paris), 146, S11 Hulscher, 2002, Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus, N Engl J Med, 347, 1662, 10.1056/NEJMoa022343 Omloo, 2007, Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial, Ann Surg, 246, 992, 10.1097/SLA.0b013e31815c4037 Sasako, 2006, Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial, Lancet Oncol, 7, 644, 10.1016/S1470-2045(06)70766-5 Sauvanet, 2005, Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors, J Am Coll Surg, 201, 253, 10.1016/j.jamcollsurg.2005.02.002 Martin, 2002, Extended local resection for advanced gastric cancer: increased survival versus increased morbidity, Ann Surg, 236, 159, 10.1097/00000658-200208000-00003 Gemmill, 2007, Systematic review of minimally invasive resection for gastro-oesophageal cancer, Br J Surg, 94, 1461, 10.1002/bjs.6015 Mariette C. Open versus laparoscopically-assisted esophagectomy for cancer. http://clinicaltrials.gov/ct2/show/NCT00937456 (accessed Jan 6, 2010). Falcone, 2003, Future strategies and adjuvant treatment of gastric cancer, Ann Oncol, 14, ii45, 10.1093/annonc/mdg729 Sun, 2009, Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer, Br J Surg, 96, 26, 10.1002/bjs.6408 Kelsen, 1998, Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer, N Engl J Med, 339, 1979, 10.1056/NEJM199812313392704 Allum, 2009, Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer, J Clin Oncol, 27, 5062, 10.1200/JCO.2009.22.2083 Cunningham, 2006, Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer, N Engl J Med, 355, 11, 10.1056/NEJMoa055531 Boige, 2007, Final results of a randomized trial comparing preoperative 5-fl uorouracil (F) /cisplatine (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial, Proc Am Soc Clin Oncol, 25, abstr 4510, 10.1200/jco.2007.25.18_suppl.4510 Thirion, 2007, Individual patient data-based meta-analysis assessing preoperative chemotherapy in resectable oesophageal carcinoma, Proc Am Soc Clin Oncol, 25, abstr 4512, 10.1200/jco.2007.25.18_suppl.4512 Walsh, 1996, A comparison of multimodal therapy and surgery for esophageal adenocarcinoma, N Engl J Med, 335, 462, 10.1056/NEJM199608153350702 Urba, 2001, Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma, J Clin Oncol, 19, 305, 10.1200/JCO.2001.19.2.305 Burmeister, 2005, Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial, Lancet Oncol, 6, 659, 10.1016/S1470-2045(05)70288-6 Tepper, 2008, Phase III trial of trimodality therapy with cisplatin, fl uorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781, J Clin Oncol, 26, 1086, 10.1200/JCO.2007.12.9593 Thirion, 2008, Individual patient databased meta-analysis assessing the effect of preoperative chemoradiotherapy in resectable oesophageal carcinoma, Int J Radiat Oncol Biol Phys, 72, S71, 10.1016/j.ijrobp.2008.06.929 Gaast, 2010, Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: results from a multicenter randomized phase III study, Proc Am Soc Clin Oncol, 28, abstr 4004, 10.1200/jco.2010.28.15_suppl.4004 Mariette, 2010, Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: analysis of a randomized controlled phase III trial FFCD 9901, J Clin Oncol, 28 Gunderson, 2002, Gastric cancer--patterns of relapse after surgical resection, Semin Radiat Oncol, 12, 150, 10.1053/srao.2002.30817 Hallissey, 1994, The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up, Lancet, 343, 1309, 10.1016/S0140-6736(94)92464-3 Macdonald, 2001, Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction, N Engl J Med, 345, 725, 10.1056/NEJMoa010187 Macdonald, 2009, Chemoradiation of resected gastric cancer: a 10-year follow-up of the phase III trial INT0116 (SWOG 9008), Proc Am Soc Clin Oncol, 27, abstr 4515, 10.1200/jco.2009.27.15_suppl.4515 Fuchs, 2006 Stahl, 2009, Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction, J Clin Oncol, 27, 851, 10.1200/JCO.2008.17.0506 Gebski, 2007, Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis, Lancet Oncol, 8, 226, 10.1016/S1470-2045(07)70039-6 Mariette, 2011, Oesophagogastric junction adenocarcinoma: Which therapeutic approach?, Lancet Oncol, 12, 296, 10.1016/S1470-2045(10)70125-X